• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Amgen

Amgen

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Amgen's Repatha Study Shows Reduced Risk of Heart Attack, Stroke -- 3rd Update

    Amgen's Repatha Study Shows Reduced Risk of Heart Attack, Stroke -- 3rd Update

  2. Amgen's Repatha Study Shows Reduced Risk of Heart Attack, Stroke -- 2nd Update

    Amgen's Repatha Study Shows Reduced Risk of Heart Attack, Stroke -- 2nd Update

  3. Ovarian Cancer Treatment Landscape & Competitive Analysis, 2017 - Research and Markets

    Ovarian Cancer Treatment Landscape & Competitive Analysis, 2017 - Research and Markets

  4. UPDATE: Stock market treads water at the open, but on track for weekly jump

    UPDATE: Stock market treads water at the open, but on track for weekly jump

  5. Republican health-care bill would be credit negative for hospitals, pharma and medical device makers in 2020: Moody's

    Republican health-care bill would be credit negative for hospitals, pharma and medical device makers in 2020: Moody's

  6. UPDATE: Republican health-care bill would be credit negative for hospitals, pharma and medical device makers in 2020: Moody's

    UPDATE: Republican health-care bill would be credit negative for hospitals, pharma and medical device makers in 2020: Moody's

  7. UPDATE: Pharma says high prices fund drug development -- but this study finds otherwise

    UPDATE: Pharma says high prices fund drug development -- but this study finds otherwise

  8. News Highlights: Top Company News of the Day

    News Highlights: Top Company News of the Day

  9. News Highlights: Top Company News of the Day

    News Highlights: Top Company News of the Day

  10. DNAnexus Announces Two Key Executive Appointments

    DNAnexus Announces Two Key Executive Appointments

12345

©2017 Morningstar Advisor. All right reserved.